Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIFOS: Fosfomycin for UTI Prophylaxis in Kidney Transplant
NCT03235947Phase 4Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Sep 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fosfomycin disodium in urinary tract infection (UTI) (2 arms), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Primary endpoint: Mean number of episodes of urinary tract infection and asymptomatic bacteriuria at 7 weeks. Started Sep 2016; status: completed.
02
Drugs
fosfomycin disodium
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03235947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03235947.